| Incidence Rate per 100 Patient-years†| ||
---|---|---|---|
 | Sitagliptin 100 mg | Non-exposed | Difference between Sitagliptin and Non-exposed (95% CI)* |
With one or more adverse events | 153.5 | 162.6 | -7.6 (-15.6, 0.3) |
With drug-related‡ adverse events | 20.0 | 26.8 | -6.4 (-8.7, -4.1) |
With serious adverse events | 7.8 | 7.9 | -0.1 (-1.3, 1.1) |
With serious drug-related‡ adverse events | 0.4 | 0.3 | 0.1 (-0.1, 0.4) |
Who died | 0.3 | 0.5 | -0.2 (-0.5, 0.1) |
Discontinued due to adverse events | 4.8 | 5.2 | -0.5 (-1.5, 0.4) |
Discontinued due to drug-related‡ adverse events | 1.7 | 2.3 | -0.5 (-1.1, 0.1) |
Discontinued due to serious adverse events | 1.7 | 1.7 | -0.0 (-0.6, 0.5) |
Discontinued due to serious drug-related‡ adverse events | 0.2 | 0.1 | 0.1 (-0.1, 0.3) |